|
|
|
|
Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 201
eline NEW YORK, Feb.9 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0176226/Whats-Next-in-Vaccines-HIV-Malaria-Rabies-MRSA-and-30-Other-Vaccine-Targets-in...
|
|
|
Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline PR Newswire NEW YORK, Feb.9 NEW YORK, Feb. 9 /PRNewswire/ -- Reportlinker.com announces that a new is available in its catalogue: http://www.reportlinker.com/p0176226/Whats-Next-in-...
|
|
|
Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
PR Newswire NEW YORK, Feb.9 NEW YORK, Feb. 9 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0176226/Whats-Next-in-Vaccines-HIV-Malaria-Rabies-MRSA-and-30-Other-...
|
|
|
Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 201
NEW YORK, Feb.9 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0176226/Whats-Next-in-Vaccines-HIV-Malaria-Rabies-MRSA-and-30-Other-Vaccine-Targets-in-the...
|
|
|
Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 201
NEW YORK, Feb.9 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0176226/Whats-Next-in-Vaccines-HIV-Malaria-Rabies-MRSA-and-30-Other-Vaccine-Targets-in-the...
|
|
|
HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many pharmaceutical companies are working on new prophylactics, some of which may see near-term marketing.What illnesses may see a ...
|
|
|
Immunization: New immunization data have been reported by researchers at Merck & Company, Inc.
Today's Medical & Research News Immunization New immunization data have been reported by researchers at Merck & Company, Inc.February 9th, 2010 Printer-Friendly Version City:North Wales State:Pennsylvania Country:United States Biotechnology...
|
|
|
Predicting effectiveness of flu vaccination campaigns
A new study, published by Elsevier this month in Vaccine Last year, an outbreak of a novel strain of influenza linked to swine influenza was detected in Mexico.The infection has shown sustained human-to-human transmission across the world, leading the...
|
|
|
Parent Concerns Hinder National H1N1 Immunization Efforts
Ask any health professional who cares for children and they will tell you: When H1N1 flu hits, it can be very severe.In the last four months of 2009, nearly 240 children died in the United States from H1N1 flu more than three times as many child deaths as in...
|
|
|
Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 201
NEW YORK, Feb.9 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many...
|
|
|
Predicting effectiveness of flu vaccination campaigns
A new study (doi:10.1016/j.vaccine.2010.01.002), published by Elsevier this month in Vaccine (http://www.elsevier.com/locate/vaccine) describes a new method that assesses the impact and cost-effectiveness of a range of vaccination options.The...
|
|
|
Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
NEW YORK, Feb.9 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many...
|
|
|
Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
NEW YORK, Feb.9 -- Reportlinker.com announces that a new market research report is available in its catalogue: The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many pharmaceutical...
|
|
|
Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
NEW YORK, Feb.9 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many...
|
|
|
Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
NEW YORK, Feb.9 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many...
|
|
|
Parental Concerns Hinder National H1N1 Immunization Efforts
Ask any health professional who cares for children and they will tell you: When H1N1 flu hits, it can be very severe.In the last four months of 2009, nearly 240 children died in the United States from H1N1 flumore than three times as many child deaths as in...
|
|
|
Swine flu vaccines extended to general population
Previous article Gary Cullitongary.culliton@imt.ieThe swine flu vaccination programme is moving into its final phase, with pandemic vaccines being made available to the general population through HSE clinics nationwide.Anyone in the target groups...
|
|
|
Pandemic H1N1 Vaccine Deployment and Vaccination Weekly Update - 05 February 2010
WHO has taken the lead in the effort to make donated pandemic influenza A (H1N1) vaccines available to 17 countries in the Western Pacific Region.All the pandemic influenza A (H1N1) vaccines to be supplied through WHO require to be prequalified....
|
|
|
Predicting effectiveness of flu vaccination campaigns
HomeReports Studies and Analyses Content A new study, published by Elsevier this month in Vaccine describes a new method that assesses the impact and cost-effectiveness of a range of vaccination options.The model was applied to the 2009 Influenza...
|
|
|
Should boys receive the HPV vaccine?
As Ireland becomes one of the last countries in the Western world to introduce a national human papillomavirus (HPV) vaccination programme for young girls, the focus is now shifting to the question of vaccinating boys against the virus, and whether...
|
|
|
GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA (AEGiS)
GeoVax Labs, Inc.Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA PRNewswire - February 8, 2010 http://www.aegis.org/news/pr/2010/PR100210.html -- Hires Clinical...
|
|
|
NY: Cervical cancer vaccine debate heading to the Legislature
Bill would allow giving vaccine to minors without parental consent ALBANY -- The debate over making cervical cancer vaccines available to young women is coming to the state Legislature today.A group of anti-vaccine activists plans to attend...
|
|
|
GeoVax Labs, Inc. Begins Enrollment At Final Site For Preventative Vaccine; Next Step Is To Submit IND Application For Therapeutic Vaccine To FDA
GeoVax Labs, Inc.(OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, provided an update on its ...
|
|
|
NY: Cervical cancer vaccine debate heading to the Legislature
Bill would allow giving vaccine to minors without parental consent ALBANY -- The debate over making cervical cancer vaccines available to young women is coming to the state Legislature today.A group of anti-vaccine activists plans to attend...
|
|
|
SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN's Ability To E
SciClone Pharmaceuticals, Inc.(NASDAQ: SCLN) and its partner Sigma-Tau S.p. A., announced additional topline results in a clinical study evaluating the potential of ZADAXIN (thymalfasin) to enhance immune response to the MF59 adjuvanted H1N1 influenza...
|
